PFAS Water Contamination Lawsuit

From the record

Internal 3M studies conducted in 1975 confirmed that PFOS levels in the blood of production workers at 3M's Cottage Grove, Minnesota manufacturing facility were approximately 1,000 times higher than levels measured in the general population. Company toxicologists characterized PFOS as exhibiting significant toxicity in animal models and recommended the compound "should be regarded as toxic." Despite these unambiguous internal findings, 3M continued manufacturing PFOS-containing products — including AFFF firefighting foam — for an additional 25 years without disclosing the known health risks to workers, fire departments, military personnel, regulatory agencies, or the communities whose water systems were contaminated by AFFF training exercises.

From the record

After eight years of analyzing health data from 69,000 Mid-Ohio Valley residents exposed to PFOA (C8) through contaminated drinking water from DuPont's Washington Works plant, the C8 Science Panel published findings establishing probable links between PFOA exposure and six specific diseases: kidney cancer, testicular cancer, thyroid disease, ulcerative colitis, high cholesterol (hypercholesterolemia), and pregnancy-induced hypertension (preeclampsia). The panel — comprising seven independent epidemiologists with no prior relationship to DuPont — applied a predetermined standard of scientific evidence before finding a probable link, meaning these findings represent conservative conclusions from a rigorous, adversarially-negotiated scientific process. DuPont agreed under the settlement to pay for class members' medical monitoring if the panel found probable links; it did, triggering that obligation.

From the record

EPA Region 4 inspections and testing at 3M's Decatur, Alabama manufacturing facility — which produced PFOS for decades — revealed that the plant had discharged PFAS into the Tennessee River and adjacent groundwater at concentrations far exceeding any level the EPA would later consider safe. Community water systems drawing from the Tennessee River downstream of the Decatur plant showed elevated PFAS concentrations. The EPA's correspondence with 3M following the inspection, obtained through FOIA requests and litigation discovery, reveals that 3M's representatives downplayed the health significance of measured PFAS levels while simultaneously conducting internal studies indicating significant toxicity — precisely the disconnect between public representations and internal knowledge that defines failure-to-warn liability.

From the record

Internal research documents from AFFF manufacturers — including 3M, Chemguard, National Foam, and Buckeye Fire Equipment — confirm that these companies understood the environmental persistence of PFAS-containing foam formulations before they became standard equipment at military bases and commercial airports. Internal technical memoranda acknowledge that PFAS compounds do not biodegrade in soil or water and will accumulate at training sites over time. Despite this knowledge, manufacturers marketed AFFF as environmentally safe for decades, and the Department of Defense was never warned that routine training exercises would result in permanent groundwater contamination at hundreds of military installations.

From the record

A series of peer-reviewed epidemiological studies published by C8 Science Panel researchers established dose-response relationships between serum PFOA levels and incidence of kidney cancer and testicular cancer in the exposed Mid-Ohio Valley population. The Steenland et al. study found that each unit increase in PFOA serum concentration was associated with a statistically significant increase in kidney cancer incidence. The Barry et al. analysis confirmed the testicular cancer association across multiple study windows. Critically, these studies demonstrated that the cancer-PFOA association strengthens with increasing serum concentration — the hallmark of a dose-response relationship that is a cornerstone of causation analysis in toxic tort litigation.